Briakinumab

Briakinumab
NEW
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T76935-1mg 1 mg - - -

7 - 10 business days*

215.00€
TGM-T76935-10mg 10 mg - - -

7 - 10 business days*

799.00€
TGM-T76935-25mg 25 mg - - -

7 - 10 business days*

1,184.00€
TGM-T76935-50mg 50 mg - - -

7 - 10 business days*

1,592.00€
 
Description: Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the study of... more
Product information "Briakinumab"
Description: Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the study of psoriasis, rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. Target: Interleukin, IL Receptor. References: Kelly RL, et al. Target-independent variable region mediated effects on antibody clearance can be FcRn independent. MAbs. 2016 Oct,8(7):1269-1275.
Keywords: BSF415977 , ABT-874 , J 695 , A-796874.0 , ABT874 , BSF 415977
Supplier: TargetMol
Supplier-Nr: T76935

Properties

Database Information

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Briakinumab"
Write a review
or to review a product.
Viewed